2030, Drug Development and Pharmaceutical Manufacturing

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2030

Drug Development

Pharmaceutical Manufacturing

Responsible sourcing and manufacturing: Growing towards a sustainable future with Lonza

Express Pharma

JANUARY 17, 2025

Carbon contributing factors: The mitigating factors throughout the drug development process The carbon-contributing factors in the production and distribution of Capsugel capsules at Lonza can be categorised into three main areas: upstream, operational, and downstream activities.

Dosage

Dosage Pharmaceutical Manufacturing Packaging Drug Development

Building CO2-neutral, defossilised supply chains for chemicals

European Pharmaceutical Review

DECEMBER 21, 2022

2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. So, when could the goal of a net zero pharmaceutical industry be achieved?

Compounding

Compounding Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies

Pharmacist Digest

Responsible sourcing and manufacturing: Growing towards a sustainable future with Lonza

Building CO2-neutral, defossilised supply chains for chemicals

Stay Connected